Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients.

dc.contributor.authorKAPLAN MEHMET
dc.contributor.authorYAVUZ FETHİ
dc.contributor.authorILGIN KAPLAN GİZEM
dc.contributor.authorBURSA NURBANU
dc.contributor.authorVURUŞKAN ERTAN
dc.contributor.authorSUCU MEHMET MURAT
dc.contributor.authorKaplan, Mehmet
dc.date.accessioned2026-06-12T11:55:53Z
dc.date.issued2021
dc.descriptionSCI-Expanded | Q:Q4 | YÖK-Özgeçmiş
dc.identifier.doi10.14744/AnatolJCardiol.2020.17329.
dc.identifier.issn2149-2263
dc.identifier.urihttps://hdl.handle.net/20.500.11782/8134
dc.relation.ispartofThe Anatolian Journal of Cardiology
dc.titleElabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients.
dspace.entity.typePublication
relation.isAuthorOfPublication9cb8d62a-ac81-4d2d-bb54-b71d1cd59c02
relation.isAuthorOfPublication.latestForDiscovery9cb8d62a-ac81-4d2d-bb54-b71d1cd59c02

Dosyalar